Search clinical trials for: ALLOB®

Total 13839 results

Bone Therapeutics S.A

Terminated

Study on Allogeneic Osteoblastic Cells Implantation in Rescue Interbody Fusion

Failed Lumbar Fusion

Belgium
Bone Therapeutics S.A

Completed

Phase 1/2a Study on Allogeneic Osteoblastic Cells Implantation in Delayed-Union Fractures

Long Bone Delayed-Union Fracture
Bone Therapeutics S.A

Completed

Phase 2a Study on Allogeneic Osteoblastic Cells Implantation in Lumbar Spinal Fusion

Degenerative Disc Disease

Belgium
Bone Therapeutics S.A
ICON plc

Recruiting

Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture (ALLOB-TF2)

Tibial Fracture

Belgium, Czechia, France, Germany, Hungary, Poland, Spain
Anterogen Co., Ltd.

Recruiting

A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease

Crohn's Disease

Korea, Republic of
Poseida Therapeutics, Inc.
Roche-Genentech

Recruiting

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL)

United States
National Research Center for Hematology, Russia
Federal Research Clinical Center of Federal Medical & Biological Agency,... and other collaborators

Recruiting

The Role of Allo-HSCT in MRD-negative Patients With AML Under the Age of 60 Years in the First Complete Remission

AML

Russian Federation
bluebird bio

Terminated

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Cerebral Adrenoleukodystrophy (CALD) | Adrenoleukodystrophy (ALD) | X-Linked Adrenoleukodystrophy (X-ALD)

United States, United Kingdom, Argentina, Canada, Germany, Italy, Netherlands
Hebei Medical University Third Hospital

Unknown

Study of PLGA-Mg Material in Clinical Orthopedics

Fracture Dislocation

China
Peking University Third Hospital

Recruiting

The Clinical Study of 3D-printed Magnesium Alloy Prosthesis With Controllable Degradation Rate in the Repair of Periarticular Bone Defects

Degradation of Magnesium Alloy Prosthesis and New Bone Regeneration

China
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans"

Diabetic Neuropathic Ulcer

Germany
Hanyang University Seoul Hospital
Corestem, Inc.

Completed

Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Neuromuscular Disease | Central Nervous System Disease | Neurodegenerative Disease

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound

Burn

Korea, Republic of
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of CVU

Skin Ulcer Venous Stasis Chronic

Germany
Anterogen Co., Ltd.

Completed

Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers

Diabetic Foot Ulcer

Korea, Republic of
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Epidermolysis Bullosa

United States
Rapa Therapeutics LLC
Hackensack Meridian Health

Terminated

RAPA-501-Allo Therapy of COVID-19-ARDS

Severe COVID-19 Disease

United States
Poseida Therapeutics, Inc.
Roche-Genentech

Recruiting

P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma (MM)

Multiple Myeloma

United States
Guangdong Ruishun Biotech Co., Ltd
Anhui Provincial Hospital

Recruiting

RC1012 Injection (Allo-DNT Cells) for the Prevention of Relapse in AML Patients After Allo-HSCT

Acute Myeloid Leukemia

China
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of
Anterogen Co., Ltd.

Recruiting

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

United States
Anterogen Co., Ltd.

Recruiting

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

Diabetic Foot Ulcer

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of
United States Army Research Institute of Environmental...

Completed

Impact of Erythropoietin on Hematological Adaptations and Physical Performance

Physical Performance | Exercise-Induced Anemia

United States
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Epidermolysis Bullosa

Austria
University of Miami
National Heart, Lung, and Blood Institute (NHLBI); The Emmes Company, LLC

Completed

The Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis Pilot Study (The POSEIDON-Pilot Study)

Stem Cell Transplantation

United States
Mayo Clinic

Active, not recruiting

REcycled CartiLage Auto/Allo IMplantation

Cartilage Defect

United States
Poseida Therapeutics, Inc.

Recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

Renal Cell Carcinoma | Breast Cancer | Nasopharyngeal Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma

United States
Azienda Socio Sanitaria Territoriale degli Spedali...
Janssen Diagnostics, LLC

Completed

CEC Count Changes to Support GvHD Diagnosis. (ALLOCEC)

Endothelial Dysfunction | Graft vs Host Disease | Complications of Organ Transplant Stem Cells

Italy
University of Miami

Temporarily not available

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND) (EXPAND)

Stroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain Attack

United States
National Cancer Institute (NCI)

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

Multiple Myeloma | Chronic Lymphocytic Leukemia | Graft vs Host Disease | Non Hodgkin's Lymphoma | Hodgkin's Disease

United States
Guangdong Ruishun Biotech Co., Ltd
First Affiliated Hospital of Zhejiang University

Recruiting

Phase I Clinical Trial of RC1012 Injection in Patients With r/r AML

Acute Myeloid Leukemia

China
Novartis Pharmaceuticals

Completed

Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)

Diffuse Large B-cell Lymphoma (DLBCL)

United States
Yonsei University

Completed

Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study

Fecal Incontinence

Korea, Republic of
Arthrosi Therapeutics

Completed

Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients

Gout Patients

New Zealand
RHEACELL GmbH & Co. KG
FGK Clinical Research GmbH; Ticeba GmbH; Granzer Regulatory Consulting & Services

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Recessive Dystrophic Epidermolysis Bullosa

United States, Austria, France, Germany, United Kingdom
Anterogen Co., Ltd.

Completed

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers

Diabetic Foot Ulcer

Korea, Republic of
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-CD in ALLO-ASC-CD-101 Clinical Trial

Crohn Disease

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects

Burn Injury

Korea, Republic of
Seoul National University Hospital
Medical Research Collaborating Center, Seoul, Korea

Completed

Treatment of Tendon Injury Using Mesenchymal Stem Cells (ALLO-ASC)

Lateral Epicondylitis

Korea, Republic of
Andalusian Initiative for Advanced Therapies -...
Iniciativa Andaluza en Terapias Avanzadas

Withdrawn

Transplantation of Hematopoietic Progenitors From Haploidentical Donor With Selective in Vitro Depletion Allo-reactive Lymphocytes in Patient With High Risk Hematological Malignancies

Transplant-Related Hematologic Malignancy

Spain
Anterogen Co., Ltd.

Recruiting

Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers

Diabetic Foot Ulcer

United States
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial

Burn

Korea, Republic of
M.D. Anderson Cancer Center

Withdrawn

Use of Water Warming/Cooling Garment to Maintain a Constant Intraoperative Core Target Temperature in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Proof-of-Concept Study

Hyperthermic Intraperitoneal

United States
Anterogen Co., Ltd.

Completed

Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula (ALLO-ASC)

Crohn

Korea, Republic of
Joshua M Hare

Withdrawn

AlloGeneic Human Mesenchymal Stem Cells (hMSC) in PAtients With FistuLizing Crohn's Disease Via PErifistula iNjEctions (GALENE) (GALENE)

Crohn's Disease | Stem Cells | Fistulizing Crohn's Disease

United States
Anterogen Co., Ltd.

Completed

Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

Tennis Elbow

Korea, Republic of
PT. Prodia Stem Cell Indonesia

Recruiting

Autologous Dendritic Cells and Allogenic Dendritic Secretomes for Patients With Advanced Nasopharyngeal Cancer

Nasopharyngeal Cancer

Indonesia
Anterogen Co., Ltd.

Completed

Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

Korea, Republic of
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of

Search clinical trials for: ALLOB®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations